Clinical Trials Browser

Interventional × Prostatic Neoplasms × Standard of Care × Clear all

NCT04396808 2026-04-15

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

Phase NA Active not recruiting

Prostatic Neoplasms

NCT05487846 2026-04-14

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Phase NA Recruiting

Prostatic Neoplasms

NCT07126548 2026-04-06

A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07512076 2026-04-06

A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

Phase 2 Not yet recruiting

Prostatic Neoplasms

NCT04905082 2026-03-24

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

Phase NA Active not recruiting

465 enrolled 11 charts

BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06422455 2026-03-18

Access to Genetic Testing in Underserved Patients With Cancer

Phase NA Recruiting

BreastGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT06855277 2026-02-24

AcTFirst

Phase 3 Recruiting

Prostatic Neoplasms

NCT06037863 2026-02-23

Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial

Phase NA Active not recruiting

Prostatic Neoplasms

NCT04876651 2026-02-20

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Phase 3 Terminated

Prostatic Neoplasms

NCT06563388 2026-02-04

ID-COMET

Phase 3 Recruiting

GastrointestinalGenitourinaryThoracic

Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT07218718 2026-01-28

Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy

Phase NA Recruiting

Prostatic Neoplasms

NCT06296147 2026-01-16

Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy

Phase NA Recruiting

Prostatic Neoplasms

NCT05519878 2025-12-24

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Phase NA Recruiting

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT03511196 2025-12-04

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

Phase EARLY_PHASE1 Active not recruiting

Prostatic Neoplasms

NCT06046131 2025-11-17

KP-CARAIBES

Phase NA Recruiting

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT05454488 2025-11-14

An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT03734653 2025-11-06

Testosterone Therapy in Castration Resistant Prostate Cancer

Phase EARLY_PHASE1 Completed

Prostatic Neoplasms

NCT06014255 2025-10-29

HEAT

Phase 2 Recruiting

Prostatic Neoplasms

NCT04751435 2025-10-21

IMAGINE

Phase NA Recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT04763915 2025-09-19

IMPACT

Phase NA Active not recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07126860 2025-08-17

ZMoveMent-1

Phase NA Recruiting

Psychological Well-Being, Motor Activity, Prostatic Neoplasms

NCT06625970 2025-06-26

PEACE 7

Phase 3 Recruiting

Prostatic Neoplasms

NCT05801965 2025-05-25

A Digital Therapeutic Solution for Cancer Patients

Phase NA Completed

GastrointestinalGenitourinaryThoracic

Lung Neoplasms, Motor Activity, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Medication Adherence

NCT03582774 2025-05-13

PSMA SRT

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT03763253 2025-02-07

IP2-ATLANTA

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT03103321 2025-01-27

Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer

Phase 3 Completed

158 enrolled 13 charts

Prostatic Neoplasms

NCT02220829 2024-12-09

Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Phase 3 Completed

Prostatic Neoplasms

NCT06636682 2024-10-21

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Phase 2 Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT03017417 2024-07-18

COMRADE

Phase NA Completed

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT04295447 2024-06-20

ADAM

Phase 2 Active not recruiting

Neoplasms, Prostatic Neoplasms

NCT00769652 2023-10-03

Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer

Phase NA Terminated

8 enrolled 6 charts

GastrointestinalGenitourinaryThoracic

Body Weight Changes, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Malnutrition, Small Cell Lung Carcinoma

NCT02957981 2023-09-13

GEM

Phase NA Completed

BreastEndocrineGastrointestinalGenitourinary

Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male, Multiple Endocrine Neoplasia Type 1

NCT03182998 2023-08-02

Decision Aids to Improve Knowledge in Patients With Prostate Cancer

Phase NA Completed

103 enrolled 12 charts

Prostatic Neoplasms

NCT05209243 2023-05-19

START-MET

Phase NA Recruiting

Prostatic Neoplasms

NCT04853095 2022-12-16

PerFix

Phase NA Completed

Lymphatic Diseases, Lymphocele, Prostatic Neoplasms

NCT04446429 2021-12-10

Anti-Androgen Treatment for COVID-19

Phase NA Completed

268 enrolled 8 charts

COVID-19, Alopecia, Prostatic Hyperplasia, Prostatic Neoplasms, Severe Acute Respiratory Syndrome

NCT04206280 2020-02-11

Use of Pedometer Following Radical Prostatectomy

Phase NA Unknown

Prostatic Neoplasms, Mobility Limitation

NCT02759783 2019-08-21

CORE

Phase 2/3 Unknown

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

NCT03988686 2019-06-17

Testing Radical Prostatectomy in Chinese Men With Prostate Cancer and oligoMetastases to the Bone

Phase NA Unknown

Prostatic Neoplasms

NCT03776045 2018-12-14

PROSCARDIO

Phase NA Completed

Motor Activity, Prostatic Neoplasms

NCT02936258 2018-02-22

PRECISE

Phase NA Unknown

Prostatic Neoplasms

NCT02252484 2016-09-07

Energy Balance for Prostate Cancer Survivorship

Phase NA Completed

Prostatic Neoplasms, Weight Loss

NCT00003674 2016-07-13

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Phase 3 Completed

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00771966 2012-10-22

Radical Prostatectomy and Perioperative Fluid Therapy

Phase 4 Completed

Prostatic Neoplasms

NCT01696539 2012-10-01

Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients

Phase NA Completed

Prostatic Neoplasms